Home/Filings/4/0001209191-18-043630
4//SEC Filing

ROCHE HOLDING LTD 4

Accession 0001209191-18-043630

CIK 0001564824other

Filed

Jul 22, 8:00 PM ET

Accepted

Jul 23, 5:05 PM ET

Size

11.9 KB

Accession

0001209191-18-043630

Insider Transaction Report

Form 4
Period: 2018-07-23
Transactions
  • Conversion

    Series B Preferrred Stock

    2018-07-23502,6320 total(indirect: See footnote)
    Common Stock (502,632 underlying)
  • Conversion

    Series A Preferrred Stock

    2018-07-234,108,0910 total(indirect: See footnote)
    Common Stock (4,108,091 underlying)
  • Conversion

    Common Stock

    2018-07-23+4,610,7234,610,723 total(indirect: See footnote)
Transactions
  • Conversion

    Common Stock

    2018-07-23+4,610,7234,610,723 total(indirect: See footnote)
  • Conversion

    Series B Preferrred Stock

    2018-07-23502,6320 total(indirect: See footnote)
    Common Stock (502,632 underlying)
  • Conversion

    Series A Preferrred Stock

    2018-07-234,108,0910 total(indirect: See footnote)
    Common Stock (4,108,091 underlying)
Footnotes (3)
  • [F1]The Series A Preferred Stock automatically converted into Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date.
  • [F2]The Series B Preferred Stock automatically converted into Common Stock on a one-for-one basis immediately prior to the closing of the Issuer's initial public offering and had no expiration date.
  • [F3]The shares are held of record by Roche Finance Ltd ("Roche Finance"). Roche Finance is a wholly owned subsidiary of Roche Holding Ltd, a publicly-held corporation.

Issuer

Allakos Inc.

CIK 0001564824

Entity typeother
IncorporatedSwitzerland

Related Parties

1
  • filerCIK 0000889131

Filing Metadata

Form type
4
Filed
Jul 22, 8:00 PM ET
Accepted
Jul 23, 5:05 PM ET
Size
11.9 KB